TIRZEE 5MG/0.5ML 1S

TIRZEE 5MG/0.5ML Injection contains Tirzepatide, a dual-acting GIP and GLP-1 receptor agonist used for effective blood sugar control in Type 2 Diabetes Mellitus. It works by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and suppressing appetite. This mid-range dose is commonly used after dose escalation and may also support weight management under medical supervision.

Uses of TIRZEE 5MG/0.5ML Injection

• Treatment of Type 2 Diabetes Mellitus

• Improving fasting and post-meal blood glucose

• Weight loss / obesity management (doctor advised)

• Reducing diabetes-related complications

Benefits

• Dual GIP + GLP-1 action for superior glycemic control

• Helps significantly reduce HbA1c

• Supports gradual and sustained weight loss

• Decreases appetite and food cravings

• Improves insulin sensitivity

• Convenient once-weekly injection

Side Effects

Common side effects may include:

• Nausea

• Vomiting

• Diarrhea or constipation

• Abdominal discomfort

• Reduced appetite

• Fatigue

Rare but serious side effects:

• Pancreatitis (severe abdominal pain)

• Gallbladder disorders

• Allergic reactions

Precautions

• Use only on doctor’s prescription

• Not for Type 1 diabetes

• Caution in patients with history of pancreatitis

• Avoid during pregnancy and breastfeeding

• Regular blood glucose monitoring is recommended

Storage Instructions

• Store refrigerated at 2°C–8°C

• Do not freeze

• Keep away from direct heat and sunlight